Brent Lawlor

Acting Director, Health Canada (HC)1 communications in the past year

Lobbied by

Bristol Myers Squibb Canada

Bill C-64 (Pharmacare Act - 2024) Patented Medicine Prices Review Board (PMPRB) Reform Most Favored Nation National Pharmacare Drugs for Rare Diseases

Recent activity

Apr 2, 2026

Elaine Phillips contacted Brent Lawlor on behalf of Bristol Myers Squibb Canada

Frequent lobbyist contacts

Elaine PhillipsBristol Myers Squibb Canada1